Streetbeat News

Revenues

PFGC

Performance Food Group (PFG) has raised its fiscal year 2025 net sales forecast to $62.5B-$63.5B and adjusted EBITDA to $1.7B-$1.8B, incorporating expected results from Cheney Brothers starting October 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 8:25 pm

ICCC

ImmuCell Corporation (Nasdaq: ICCC) reported preliminary Q3 2024 revenue of $6 million, up 11% from $5.4 million YoY. The company also reported significant revenue growth for the nine- and twelve-month periods, with a strong order backlog of $7.3 million, indicating robust demand.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 8:08 pm

SAR

Saratoga Investment (NYSE:SAR) reported strong Q2 2025 results, with adjusted EPS of $1.33 beating estimates by 41.49% and sales of $43.003M surpassing expectations by 15.84%. This marks a 21.09% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 8:08 pm

BA

S&P estimates that the ongoing strike is costing Boeing over $1 billion per month, even after implementing cost-saving measures.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 8:02 pm

PRCT

Analysts have shown a predominantly bullish sentiment towards PROCEPT BioRobotics (NASDAQ:PRCT) over the past three months, with a notable increase in average price targets. The company's financials reveal strong revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:01 pm

GFS

GLOBALFOUNDRIES (NASDAQ:GFS) has received mixed analyst ratings over the past three months, with a decrease in the average 12-month price target from $62.83 to $56.83. Analysts have adjusted their ratings and price targets in response to market conditions, with some lowering their targets. The company faces financial challenges, including a decline in revenue growth and below-average net margin, ROE, and ROA compared to industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:01 pm

WAT

Analysts have provided mixed ratings for Waters (NYSE:WAT) over the past three months, with a recent trend towards more bullish sentiments. The average 12-month price target has increased by 9.2% to $354.0. Despite revenue challenges, Waters shows strong profitability and financial management, though it carries a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:00 pm

PDCO

In the past three months, 6 analysts have provided ratings for Patterson Cos (NASDAQ:PDCO), with a mix of bullish and indifferent sentiments. The average 12-month price target has decreased from $27.50 to $25.33. Analysts have lowered their price targets, reflecting changing market dynamics and company performance. Patterson Cos faces challenges with a -2.22% revenue decline, but maintains strong net margins and effective debt management.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:00 pm

WMB

Williams Companies (NYSE:WMB) has delivered an impressive annualized return of 16.17% over the past 5 years, outperforming the market by 2.03%. A $1000 investment in WMB 5 years ago would now be worth $2,118.99, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:00 pm

CIEN

Ciena Inc. (NYSE:CIEN) has seen a significant stock price increase, with a 23.69% rise over the past month and 47.08% over the past year. Despite this, its P/E ratio of 67.65 is lower than the industry average of 147.06, suggesting potential undervaluation or lower growth expectations compared to peers.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:00 pm